Results 221 to 230 of about 1,535,680 (331)

Anti-drug antibody formation in Japanese Fabry patients following enzyme replacement therapy. [PDF]

Mol Genet Metab Rep, 2020
Tsukimura T, Tayama Y, Shiga T, Hirai K, Togawa T, Sakuraba H.   +5 more
europepmc   +1 more source

Studies on the Adjuvant Action of Bacterial Endotoxins on Antibody Formation

, 1963
Katharine Merritt, Arthur G. Johnson
openalex   +1 more source

Affinity of antigen for white cells and its relation to the induction of antibody formation [PDF]

, 1968
D Sulitzeanu
openalex   +1 more source

Survivin and Aurora Kinase A control cell fate decisions during mitosis

Molecular Oncology, EarlyView.
Aurora A interacts with survivin during mitosis and regulates its centromeric role. Loss of Aurora A activity mislocalises survivin, the CPC and BubR1, leading to disruption of the spindle checkpoint and triggering premature mitotic exit, which we refer to as ‘mitotic slippage’.
Hana Abdelkabir, Shalitha Wickrama Arachchige, Sally P. Wheatley   +2 more
wiley   +1 more source

Tofacitinib to prevent anti-drug antibody formation against LMB-100 immunotoxin in patients with advanced mesothelin-expressing cancers. [PDF]

Front Oncol
Skorupan N, Peer CJ, Zhang X, Choo-Wosoba H, Ahmad MI, Lee MJ, Rastogi S, Sato N, Yu Y, Pegna GJ, Steinberg SM, Kalsi SS, Cao L, Figg WD, Trepel JB, Pastan I, FitzGerald D, Alewine C.   +17 more
europepmc   +1 more source

CDK11 inhibition induces cytoplasmic p21WAF1 splice variant by p53 stabilisation and SF3B1 inactivation

Molecular Oncology, EarlyView.
CDK11 inhibition stabilises the tumour suppressor p53 and triggers the production of an alternative p21WAF1 splice variant p21L, through the inactivation of the spliceosomal protein SF3B1. Unlike the canonical p21WAF1 protein, p21L is localised in the cytoplasm and has reduced cell cycle‐blocking activity.
Radovan Krejcir, Lukasz Arcimowicz, Lucia Martinkova, Vaclav Hrabal, Filip Zavadil Kokas, Tomas Henek, Martina Kucerikova, Ondrej Bonczek, Pavlina Zatloukalova, Lenka Hernychova, Philip J. Coates, Borivoj Vojtesek, David P. Lane   +12 more
wiley   +1 more source

The effect of COVID-19 vaccination on kidney function and HLA antibody formation in patients with end-stage kidney disease and on kidney replacement treatment. [PDF]

Clin Kidney J
Imhof C, Messchendorp AL, Bungener LB, Hepkema BG, Kho MML, Reinders MEJ, Bemelman FJ, Hilbrands LB, Gansevoort RT, Sanders JSF, RECOVAC Consortium .   +10 more
europepmc   +1 more source

Reduced vascular leakage correlates with breast carcinoma T regulatory cell infiltration but not with metastatic propensity

Molecular Oncology, EarlyView.
A mouse model for vascular normalization and a human breast cancer cohort were studied to understand the relationship between vascular leakage and tumor immune suppression. For this, endothelial and immune cell RNAseq, staining for vascular function, and immune cell profiling were employed.
Liqun He, Chiara Testini, Neda Hekmati, Altea Bonello, Aglaia Schiza, Emmanuel Nwadozi, Mia Phillipson, Carina Strell, Michael Welsh   +8 more
wiley   +1 more source

Antibiotics influence the risk of anti-drug antibody formation during anti-TNF therapy in Chinese inflammatory bowel disease patients. [PDF]

Front Pharmacol
Sun M, Ju J, Xu H, Luo M, Li Z, Wang Y.
europepmc   +1 more source

Antibody Formation, Latency and Leukemia: Infection with Moloney Virus [PDF]

, 1966
Natalie E. Cremer, Dee O. N. Taylor, Shirley J. Hagens   +2 more
openalex   +1 more source